What is the market doing?
What the tape says about RARE
Ultragenyx Pharmaceutical Inc. is −50% over the past year while the S&P 500 is +20%: 70 points behind the market.
−50%
1-year return · S&P 500 +20%
- vs 200-day average
- −43%
vs 200-day average · a clear downtrend
- RSI (14)
- 18
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 59%
Below its 52-week high
Details›
- Last close2026-09-08
- $14.88
- 1 monthS&P 500 −0.30%
- −42%
- 1 yearS&P 500 +20%
- −50%
- 5 yearsS&P 500 +85%
- −84%
- vs 50-day average$26.04
- −43%
- 52-week high
- $36.54
- 52-week low
- $14.83
- Annualised volatility
- 66%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$2.4M
| Year | Return |
|---|---|
| 2026 (year to date) | −35% |
| 2025 | −45% |
| 2024 | −12% |
| 2023 | +3.2% |
| 2022 | −45% |
| 2021 | −39% |
| 2020 | +224% |
| 2019 | −1.8% |
| 2018 | −6.3% |
| 2017 | −34% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +3.8% |
| Feb | 10 | 5 of 10 | +5.1% |
| Mar | 10 | 3 of 10 | −8.4% |
| Apr | 10 | 4 of 10 | +4.7% |
| May | 10 | 3 of 10 | −2.7% |
| Jun | 10 | 8 of 10 | +9.6% |
| Jul | 11 | 4 of 11 | −2.4% |
| Aug | 11 | 6 of 11 | +2.3% |
| Sep | 11 | 2 of 11 | −9.0% |
| Oct | 10 | 2 of 10 | −5.4% |
| Nov | 10 | 6 of 10 | +5.3% |
| Dec | 10 | 5 of 10 | +0.42% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.